Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05404230 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities

Study acronym: OxaNeuro
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from May 2026 to Dec 2027
    • Trial sites expanded: 1 → 4 locations
    • Study completion pushed from Dec 2026 to Dec 2028
    v8
  2. Primary completion date: Mar 2026 to May 2026v7
  3. Primary completion date: Dec 2024 to Mar 2026v6
  4. Re-verified, no change to tracked fieldsv5
  5. Primary completion date: Apr 2024 to Dec 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2022 to Jul 15, 2022
    v3
  2. Secondary endpoints revised (2)v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.
Trial Details
NCT Number NCT05404230
Lead Sponsor Vejle Hospital
Conditions
(from sponsor)		 Peripheral Neuropathy, Colorectal Cancer
Related terms Colorectal Neoplasms, Peripheral Nervous System Diseases
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov